These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30764699)

  • 21. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.
    Beale AL; Nanayakkara S; Segan L; Mariani JA; Maeder MT; van Empel V; Vizi D; Evans S; Lam CSP; Kaye DM
    JACC Heart Fail; 2019 Mar; 7(3):239-249. PubMed ID: 30819380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aortic Waveform Analysis to Individualize Treatment in Heart Failure.
    Wohlfahrt P; Melenovsky V; Redfield MM; Olson TP; Lin G; Abdelmoneim SS; Hametner B; Wassertheurer S; Borlaug BA
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28159826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulsatile hemodynamics in patients with exertional dyspnea: potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction.
    Weber T; Wassertheurer S; O'Rourke MF; Haiden A; Zweiker R; Rammer M; Hametner B; Eber B
    J Am Coll Cardiol; 2013 May; 61(18):1874-83. PubMed ID: 23500307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of Pulsatile Left Ventricular Afterload by Renal Denervation in Heart Failure With Preserved Ejection Fraction.
    Rommel KP; Pagoulatou S; Kresoja KP; Rosch S; Schöber AR; von Roeder M; Thiele H; Fengler K; Stergiopulos N; Lurz P
    Circ Heart Fail; 2023 Oct; 16(10):e010543. PubMed ID: 37646196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.
    Green P; Babu BA; Teruya S; Helmke S; Prince M; Maurer MS
    Congest Heart Fail; 2013; 19(4):172-9. PubMed ID: 23517485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
    Borlaug BA; Lewis GD; McNulty SE; Semigran MJ; LeWinter M; Chen H; Lin G; Deswal A; Margulies KB; Redfield MM
    Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction.
    Ali D; Tran P; Ennis S; Powell R; McGuire S; McGregor G; Kimani PK; Weickert MO; Miller MA; Cappuccio FP; Banerjee P
    ESC Heart Fail; 2023 Aug; 10(4):2487-2498. PubMed ID: 37280726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between sleep-disordered breathing and arterial stiffness in heart failure patients with reduced or preserved ejection fraction.
    Suzuki S; Yoshihisa A; Sato Y; Watanabe S; Yokokawa T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
    ESC Heart Fail; 2018 Jun; 5(3):284-291. PubMed ID: 29460495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular and proximal aorta coupling in magnetic resonance imaging: aging together?
    Redheuil A; Kachenoura N; Bollache E; Yu WC; Opdahl A; Decesare A; Mousseaux E; Bluemke D; Lima JAC
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H300-H307. PubMed ID: 30978118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of Left Ventricular Structure and Function With Blood Pressure in Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.
    Wei FF; Xue R; Thijs L; Liang W; Owusu-Agyeman M; He X; Staessen JA; Dong Y; Liu C
    J Am Heart Assoc; 2020 Aug; 9(15):e016009. PubMed ID: 32750310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
    Shah AM; Claggett B; Sweitzer NK; Shah SJ; Anand IS; O'Meara E; Desai AS; Heitner JF; Li G; Fang J; Rouleau J; Zile MR; Markov V; Ryabov V; Reis G; Assmann SF; McKinlay SM; Pitt B; Pfeffer MA; Solomon SD
    Circ Heart Fail; 2014 Sep; 7(5):740-51. PubMed ID: 25122186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of pulse wave velocity and central pulse pressure in heart failure with reduced ejection fraction.
    Kõre AC; Joonsalu T; Serg M; Pauklin P; Voitk J; Roose I; Eha J; Kampus P
    Blood Press; 2024 Dec; 33(1):2359932. PubMed ID: 38819846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular responses to acute changes in late systolic pressure augmentation in older adults.
    Sweitzer NK; Hetzel SJ; Skalski J; Velez M; Eggleston K; Mitchell GF
    Am J Hypertens; 2013 Jul; 26(7):866-71. PubMed ID: 23537892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.
    Tada A; Burkhoff D; Naser JA; Harada T; Pourmussa B; Reddy YNV; Jensen MD; Carter RE; Demmer RT; Testani JM; Chirinos JA; Borlaug BA
    Circulation; 2024 Sep; 150(13):997-1009. PubMed ID: 39101201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.